Andrey A. Kolokoltsov

2.7k total citations · 1 hit paper
32 papers, 2.1k citations indexed

About

Andrey A. Kolokoltsov is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Andrey A. Kolokoltsov has authored 32 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 11 papers in Molecular Biology. Recurrent topics in Andrey A. Kolokoltsov's work include Viral Infections and Outbreaks Research (12 papers), Mosquito-borne diseases and control (9 papers) and Viral Infections and Vectors (7 papers). Andrey A. Kolokoltsov is often cited by papers focused on Viral Infections and Outbreaks Research (12 papers), Mosquito-borne diseases and control (9 papers) and Viral Infections and Vectors (7 papers). Andrey A. Kolokoltsov collaborates with scholars based in United States, Russia and Germany. Andrey A. Kolokoltsov's co-authors include Robert A. Davey, Mohammad Saeed, Thomas Albrecht, Yasuteru Sakurai, Christian Wahl‐Schott, William E. Bauta, Cheng‐Chang Chen, Michael Tidwell, Martin Biel and Christian Grimm and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nano Letters.

In The Last Decade

Andrey A. Kolokoltsov

31 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment

2015 421 citations Yasuteru Sakurai, Andrey A. Kolokoltsov et al. Science profile →

Peers

Countries citing papers authored by Andrey A. Kolokoltsov

Since Specialization

Citations

This map shows the geographic impact of Andrey A. Kolokoltsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrey A. Kolokoltsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrey A. Kolokoltsov more than expected).

Fields of papers citing papers by Andrey A. Kolokoltsov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrey A. Kolokoltsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrey A. Kolokoltsov. The network helps show where Andrey A. Kolokoltsov may publish in the future.

Co-authorship network of co-authors of Andrey A. Kolokoltsov

This figure shows the co-authorship network connecting the top 25 collaborators of Andrey A. Kolokoltsov. A scholar is included among the top collaborators of Andrey A. Kolokoltsov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrey A. Kolokoltsov. Andrey A. Kolokoltsov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment breakdown → 2015 ·Science ·Yasuteru Sakurai, Andrey A. Kolokoltsov, Cheng‐Chang Chen, Michael Tidwell, William E. Bauta, Norbert Klugbauer, Christian Grimm, Christian Wahl‐Schott, Martin Biel, Robert A. Davey	421
2	A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents 2013 ·PLoS ONE ·Peter B. Madrid, Sidharth Chopra, Ian D. Manger, Lynne Gilfillan, Tiffany R. Keepers, Amy C. Shurtleff, Carol E. Green, Lalitha Iyer, Holli H. Dilks, Robert A. Davey, Andrey A. Kolokoltsov, Ricardo E. Carrión, Jean L. Patterson, Sina Bavari, Rekha G. Panchal, Travis K. Warren, Jay Wells, Walter H. Moos, (unknown), Mary J. Tanga	188
3	Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin 2011 ·Archives of Virology ·Andrey A. Kolokoltsov, (unknown), (unknown), (unknown), Robert A. Davey, Eric M. Vela	36
4	Differential, Type I Interferon-Mediated Autophagic Trafficking of Hepatitis C Virus Proteins in Mouse Liver 2011 ·Gastroenterology ·(unknown), Bin Gong, Teh‐Sheng Chan, Robert A. Davey, Lynn Soong, Andrey A. Kolokoltsov, Jiaren Sun	28
5	Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes 2010 ·PLoS Pathogens ·Mohammad Saeed, Andrey A. Kolokoltsov, Thomas Albrecht, Robert A. Davey	337
6	Effective suppression of Dengue fever virus in mosquito cell cultures using retroviral transduction of hammerhead ribozymes targeting the viral genome 2009 ·Virology Journal ·Pruksa Nawtaisong, (unknown), Tresa S. Fraser, Velmurugan Balaraman, Andrey A. Kolokoltsov, Robert A. Davey, Stephen Higgs, (unknown), Yupha Rongsriyam, Narumon Komalamisra, Malcolm J. Fraser	23
7	Identification of novel cellular targets for therapeutic intervention against Ebola virus infection by siRNA screening 2009 ·Drug Development Research ·Andrey A. Kolokoltsov, Mohammad Saeed, Alexander N. Freiberg, Michael R. Holbrook, Robert A. Davey	30
8	CCK₂receptor expression transforms non‐tumorigenic human NCM356 colonic epithelial cells into tumor forming cells 2009 ·International Journal of Cancer ·Celia Chao, Xueliang Han, Kirk L. Ives, (unknown), Andrey A. Kolokoltsov, Robert A. Davey, Mary Pat Moyer, Mark R. Hellmich	19
9	Alphavirus production is inhibited in neurofibromin 1-deficient cells through activated RAS signalling 2008 ·Virology ·Olga A. Kolokoltsova, Aaron M. Domina, Andrey A. Kolokoltsov, Robert A. Davey, Scott C. Weaver, Stanley J. Watowich	3
10	Phosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola Virus 2008 ·PLoS Pathogens ·Mohammad Saeed, Andrey A. Kolokoltsov, Alexander N. Freiberg, Michael R. Holbrook, Robert A. Davey	162
11	Venezuelan equine encephalitis virus infection of mosquito cells requires acidification as well as mosquito homologs of the endocytic proteins Rab5 and Rab7 2007 ·Virology ·Tonya M. Colpitts, (unknown), Andrey A. Kolokoltsov, Robert A. Davey	34
12	Venezuelan equine encephalitis virus entry mechanism requires late endosome formation and resists cell membrane cholesterol depletion 2006 ·Virology ·Andrey A. Kolokoltsov, (unknown), Robert A. Davey	45
13	Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1α expression and tumor growth 2006 ·Oncogene ·(unknown), (unknown), (unknown), Andrey A. Kolokoltsov, Robert A. Davey, Tokujiro Uchida, C. M. Townsend, Mark R. Hellmich	33
14	Determining functionally important amino acid residues of the E1 protein of Venezuelan equine encephalitis virus 2006 ·Journal of Molecular Modeling ·Surendra S. Negi, Andrey A. Kolokoltsov, Catherine H. Schein, Robert A. Davey, Werner Braun	21
15	PSEUDOTYPED VIRUSES PERMIT RAPID DETECTION OF NEUTRALIZING ANTIBODIES IN HUMAN AND EQUINE SERUM AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS 2006 ·American Journal of Tropical Medicine and Hygiene ·Andrey A. Kolokoltsov, Eryu Wang, Tonya M. Colpitts, Scott C. Weaver, Robert A. Davey	8
16	Targeting and Penetration of Virus Receptor Bearing Cells by Nanoparticles Coated with Envelope Proteins of Moloney Murine Leukemia Virus 2006 ·Nano Letters ·Drew C. Deniger, Andrey A. Kolokoltsov, (unknown), Thomas Albrecht, Robert A. Davey	16
17	Src Regulates Constitutive Internalization and Rapid Resensitization of a Cholecystokinin 2 Receptor Splice Variant 2005 ·Journal of Biological Chemistry ·Celia Chao, Kirk L. Ives, (unknown), Andrey A. Kolokoltsov, Robert A. Davey, Courtney M. Townsend, Mark R. Hellmich	15
18	The Use of Interferon for Emergency Prophylaxis of Marburg Hemorrhagic Fever in Monkeys 2001 ·Bulletin of Experimental Biology and Medicine ·Andrey A. Kolokoltsov, (unknown), (unknown), (unknown), (unknown), А. П. Агафонов	11
19	Recombinant Monoclonal Human Antibodies against Ebola Virus 2001 ·Doklady Biochemistry and Biophysics ·Nina V. Tikunova, Andrey A. Kolokoltsov, А. А. Чепурнов	2
20	[Design of human liposomal recombinant alpha2-interferon-containing preparation]. 1999 ·PubMed ·(unknown), Andrey A. Kolokoltsov, (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact